Atopic Dermatitis Market Opportunities, New Developments, Competitive Landscape from Vinit's blog

Market overview

Atopic Dermatitis is one of the most common types of eczema that is with the patients who suffer from this disease and have a super sensitive skin and a reduced threshold for irritation. It misguides the immune system in the body and leads to the development of chronic diseases. The prevalence of atopic dermatitis has increased all over the world and mostly it has been affecting infants and children. This problem includes food allergies, fever, allergic asthma, atopic dermatitis and anaphylaxis. 

The type of eczema has various patterns that depends on the age of the patients. It can occur anywhere in the body and can be characterized by a low quantity of filaggrin protein that allows for the skin to become dry and reduces the immunity ability. The market for this type of eczema is growing majorly, attributing to the prevalence of atopic disorders and the various technological developments in the medical devices field. 

Atopic dermatitis global market report showcases that the market will grow at a CAGR of 8.2% during the forecast period of 2017-2023. According to the report published by the National Center for Biotechnology Information, and the atopic dermatitis has affected around 20% of the infants and children and 3% of the adults at a global level. There has been a rising funding along with the government support for the research and development boosting the growth of the atopic dermatitis market. 

Regional Analysis

North America is the dominant region in the global atopic dermatitis market and has been assessed to lead the market over the forecast period, owing to the extensive investment in the healthcare sector, government expenditure towards healthcare research and development for advancement, growing usage of cosmetics and perfumes which lead to skin irritation, and the increasing patient population.

Europe has been accounted for the second largest market share in the global atopic dermatitis market. The market has been assessed to grow significantly due to the increasing expenditure in stable economies such as France and Germany on healthcare and ensures the affordability of  high-quality medical care by consumers owing to their steady disposable income.

The Asia Pacific has been assessed as the fastest growing region in the global atopic dermatitis market, owing to the increasing healthcare expenditure by the governments in emerging economies such as China, and India, to provide consumers with better medical facilities.

Industry news 

Astellas Pharma Inc. and Nanna Therapeutics, a biotech company, have announced an acquisition that is focused on addressing the age-related diseases with the unmet medical needs that includes the mitochondria-related diseases that enable the creation and rapid testing of more diverse chemical libraries. It enables the approach of enabling the phenotype-based screening which is not feasible. 

Previous post     
     Next post
     Blog home

The Wall

No comments
You need to sign in to comment


By Vinit
Added Jun 10


Your rate:
Total: (0 rates)